Austar Lifesciences Limited (HKG:6118)

Austar Lifesciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	164.66	166.81	163.77	133.62	198.45	177.95
Short-Term Investments	1	1	10	14.51	21.29	0.16
Cash & Short-Term Investments	165.66	167.81	173.77	148.13	219.74	178.11
Cash Growth	18.34%	-3.43%	17.31%	-32.59%	23.37%	-6.89%
Accounts Receivable	972.74	987.01	994.69	1,000	672.83	515.5
Other Receivables	16.73	31.31	26.13	20.01	27.59	5.32
Receivables	989.47	1,018	1,021	1,020	700.42	520.82
Inventory	229.09	238.43	243.16	388.11	423.26	209.24
Other Current Assets	114.81	127.21	136.08	244.35	319.82	181.11
Total Current Assets	1,499	1,552	1,574	1,801	1,663	1,089
Property, Plant & Equipment	407.62	414.13	443.85	433.61	311.81	185.93
Long-Term Investments	65.31	60.28	82.11	85.5	39.7	62.94
Goodwill	-	-	-	-	-	1.57
Other Intangible Assets	38.8	42.3	42.47	55.87	21.11	21.89
Long-Term Deferred Tax Assets	14.74	15.17	16.72	12.78	8.92	7.05
Other Long-Term Assets	2.88	-	-	-	-	-
Total Assets	2,028	2,084	2,159	2,389	2,045	1,379
Accounts Payable	412.06	382.11	405.93	426.2	352.35	296.92
Accrued Expenses	81.6	111.27	114.22	180.93	155.36	100.46
Short-Term Debt	206.05	229.75	255.31	173.55	56.09	31.41
Current Portion of Long-Term Debt	62.84	98.88	64.52	45.67	-	-
Current Portion of Leases	11.97	16.98	13.38	14.38	9.97	12.72
Current Income Taxes Payable	3.21	1.54	0.85	5.15	5.72	0.83
Current Unearned Revenue	210.24	202.26	180.19	382.71	466.69	322.18
Other Current Liabilities	108.14	145.89	143.29	131.17	90.02	41.16
Total Current Liabilities	1,096	1,189	1,178	1,360	1,136	805.68
Long-Term Debt	61.6	25.14	110.85	40.07	54.27	-
Long-Term Leases	14.71	31.2	52.14	62.87	34.89	32.34
Long-Term Unearned Revenue	0.11	0.14	0.34	0.54	0.75	0.45
Long-Term Deferred Tax Liabilities	40.03	40.18	37.84	37.74	30.25	15.8
Other Long-Term Liabilities	5.47	4.83	4.64	4.19	-	-
Total Liabilities	1,218	1,290	1,383	1,505	1,256	854.27
Common Stock	4.07	4.07	4.07	4.07	4.07	4.07
Additional Paid-In Capital	339.55	339.55	339.55	339.55	344.16	344.16
Retained Earnings	426.37	401.37	385.29	498.77	411.31	134.01
Comprehensive Income & Other	39.36	46.41	44.09	54.55	27.05	35.66
Total Common Equity	809.35	791.41	773.01	896.94	786.58	517.9
Minority Interest	1.02	2.06	2.46	-13.36	1.84	6.68
Shareholders' Equity	810.37	793.47	775.47	883.58	788.42	524.57
Total Liabilities & Equity	2,028	2,084	2,159	2,389	2,045	1,379
Total Debt	357.16	401.95	496.2	336.55	155.22	76.47
Net Cash (Debt)	-191.49	-234.15	-322.43	-188.42	64.52	101.65
Net Cash Growth	-	-	-	-	-36.53%	-23.49%
Net Cash Per Share	-0.37	-0.46	-0.63	-0.37	0.13	0.20
Filing Date Shares Outstanding	512.58	512.58	512.58	512.58	512.58	512.58
Total Common Shares Outstanding	512.58	512.58	512.58	512.58	512.58	512.58
Working Capital	402.94	363.08	396.13	441.24	527.05	283.6
Book Value Per Share	1.58	1.54	1.51	1.75	1.53	1.01
Tangible Book Value	770.55	749.11	730.54	841.08	765.47	494.44
Tangible Book Value Per Share	1.50	1.46	1.43	1.64	1.49	0.96
Buildings	-	267.41	249.41	17.37	16.62	16.45
Machinery	-	84.88	92.57	80.6	75.1	66.54
Construction In Progress	-	5.03	4.51	214.04	135.56	20.63
Order Backlog	-	1,082	1,014	1,442	1,593	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.